Rebecca Schüle
Heidelberg University, University of Tübingen, Hertie Institute for Clinical Brain Research
Research areas: Neuroscience · Cellular and Molecular Neuroscience · Hereditary Neurological Disorders · Genetic Neurodegenerative Diseases · Genomics and Rare Diseases
0000-0002-7781-2766
About
Rebecca Schüle, M.D., is an Adult Neurologist and Neuroscientist with special expertise in neurodegenerative motoneuron diseases and movement disorders. She serves as the Director of the Division of Neurodegenerative Diseases at the Heidelberg University Hospital and is Full Professor at the Ruprecht Karl University of Heidelberg in Germany. As a clinician-researcher the objective of her research is to advance novel treatments and cures for rare and ultrarare hereditary movement disorders.
Employment
-
University of Heidelberg Director, Division of Neurodegenerative Diseases and Movement Disorders2022 - Present
-
University of Tübingen Clinical Practice Director and Residency Program Director2015 - 2022
-
Hertie Institute for Clinical Brain Research Senior Faculty, Research Group Leader2015 - 2022
-
University of Miami Miller School of Medicine Marie-Curie Fellow of the European Union2013 - 2015
Education
-
University of Heidelberg Medical Doctor1995 - 2003
Projects & Funding
Projects & funding information is unavailable.
Publications (213)
- Long-read RNA-sequencing reveals transcript-specific regulation in human-derived cortical neurons Save
- Comparing randomized trial designs to estimate treatment effect in rare diseases with longitudinal models: a simulation study showcased by Autosomal Recessive Cerebellar Ataxias using the SARA score Save
- Patient-Relevant Digital-Motor Outcomes for Clinical Trials in Hereditary Spastic Paraplegia Type 7: A Multicenter PROSPAX Study. Save
- A framework for N-of-1 trials of individualized gene-targeted therapies for genetic diseases. Save
- Long-Read RNA-sequencing reveals transcript-specific regulation in human-derived cortical neurons Save
- Advancing ASO therapies from development to implementation. Save
- Comprehensive reanalysis for CNVs in ES data from unsolved rare disease cases results in new diagnoses. Save
- Longitudinal Analysis of Natural History Progression of Rare and Ultra-Rare Cerebellar Ataxias Using Item Response Theory. Save
- Sacsin levels in PBMCs: A diagnostic assay for SACS variants in peripheral blood cells - A PROSPAX study. Save
- The GENESIS database and tools: A decade of discovery in Mendelian genomics. Save
- Loss of Fic causes progressive neurodegeneration in a Drosophila model of hereditary spastic paraplegia. Save
- Model matchmaking via the Solve-RD Rare Disease Models & Mechanisms Network (RDMM-Europe). Save
- An MRI evaluation of white matter involvement in paradigmatic forms of spastic ataxia: results from the multi-center PROSPAX study. Save
- Digital Gait Outcomes for Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS): Discriminative, Convergent, and Ecological Validity in a Multicenter Study (PROSPAX). Save
- MRI-ARSACS: An Imaging Index for Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS) Identification Based on the Multicenter PROSPAX Study. Save
- Mobile digital gait analysis captures effects of botulinum toxin in hereditary spastic paraplegia. Save
- Comparative RNAseq analysis for the study of motoneuron diseases in multi-omics approaches Save
- Correction: Prediction of Individual Disease Progression Including Parameter Uncertainty in Rare Neurodegenerative Diseases: The Example of Autosomal-Recessive Spastic Ataxia Charlevoix Saguenay (ARSACS). Save
- Item performance of the scale for the assessment and rating of ataxia in rare and ultra-rare genetic ataxias. Save
- Unravelling undiagnosed rare disease cases by HiFi long-read genome sequencing Save